Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Neutral
| Metric | AMGN | IDXX |
|---|
| Close | 376.35 | 513.62 |
| Market Cap | $203B | $40.5B |
| 1M | −10.26% | −5.95% |
| P/E (TTM) | 23.3 | 35.5 |
| Forward P/E | 16.9 | 35.6 |
| P/E 5-Yr Percentile | 27 | 0 |
| P/S | 5.4 | 8.9 |
| P/B | 17.4 | 25.1 |
| Dividend Yield | 3.21% | — |
| Latest Quarter Revenue | $10.1B | $1.2B |
| Revenue YoY | +9.5% | +9.7% |
| Gross Margin | 72.0% | 64.0% |
| Latest Quarter EPS | 4.37 | 4.27 |
| Avg Post-Earnings Move | ±5.2% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 2.91% |
| 90-Day Net Insider Buying | −$4.1M | −$1.2M |
AMGN · Revenue, Last 8 Quarters ($B)
IDXX · Revenue, Last 8 Quarters ($B)
